Clearmind Medicine Announces Shareholders Meeting Results
November 15 2023 - 7:37AM
Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY)
(“Clearmind” or the “Company”), a biotech company focused on
discovery and development of novel psychedelic-derived therapeutics
to solve major under-treated health problems, is pleased to
announce that all of the matters put forward before shareholders
for consideration and approval at its meeting held on November 14,
2023 (the “Meeting”), as set out in the Company’s Management
Information Circular dated October 9, 2023, were approved by the
requisite majority of votes cast at the Meeting, including a
resolution fixing the board of directors at four members, the
election of directors of the Company for the ensuing year, a
resolution to establish and approve an omnibus equity incentive
plan and a resolution approving the directors to effect a
consolidation (the “Consolidation”) of the common shares in
the capital of the Company (the “Shares”) on the basis of fifty
(50) pre-Consolidation Shares for one (1) post-Consolidation Share,
or such other lesser consolidation ratio as determined by the
Company’s board of directors at its sole discretion, in one or more
tranches during the twelve (12) months immediately following the
Meeting.
About Clearmind Medicine Inc.
Clearmind is a psychedelic pharmaceutical biotech company
focused on the discovery and development of novel
psychedelic-derived therapeutics to solve widespread and
underserved health problems, including alcohol use disorder. Its
primary objective is to research and develop psychedelic-based
compounds and attempt to commercialize them as regulated medicines,
foods or supplements.
The Company’s intellectual portfolio currently consists of
fifteen patent families. The Company intends to seek additional
patents for its compounds whenever warranted and will remain
opportunistic regarding the acquisition of additional intellectual
property to build its portfolio.
Shares of Clearmind are listed for trading on Nasdaq and the
Canadian Securities Exchange under the symbol "CMND" and the
Frankfurt Stock Exchange under the symbol “CWY.”
For further information
visit: https://www.clearmindmedicine.com or contact:
Investor Relations invest@clearmindmedicine.com
Telephone: (604) 260-1566 US: CMND@crescendo-ir.com
General Inquiries
Info@Clearmindmedicine.com
Clearmind Medicine (NASDAQ:CMND)
Historical Stock Chart
From Apr 2024 to May 2024
Clearmind Medicine (NASDAQ:CMND)
Historical Stock Chart
From May 2023 to May 2024